Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $88,320.23 +0.55%
Ethereum $2,984.75 +1.09%
BNB $854.11 +1.39%
Optimism $0.28 +4.73%
Arbitrum $0.19 +3.97%
Solana $126.31 +1.60%
Polygon $0.22 +2.77%
Cosmos $2.00 +6.15%
Avalanche $12.34 +3.45%

Bitcoin $88,320.23 +0.55%
Ethereum $2,984.75 +1.09%
BNB $854.11 +1.39%
Optimism $0.28 +4.73%
Arbitrum $0.19 +3.97%
Solana $126.31 +1.60%
Polygon $0.22 +2.77%
Cosmos $2.00 +6.15%
Avalanche $12.34 +3.45%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed